FDA Drug recall D-0354-2023
Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50…
- FDA Drug
- Class III
- terminated
- Published 2023-03-08
On 2023-03-08 the FDA classified a Class III recall of Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50… by Sciegen Pharmaceuticals, citing presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0354-2023 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2023-02-17 |
| Published | 2023-03-08 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Sciegen Pharmaceuticals |
| Distribution | US |
Product
Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50228-177-05.
Reason
Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.
Identifiers
| ndc | 50228-177-30 |
|---|---|
| ndc | 50228-177-01 |
| ndc | 50228-177-05 |
| ndc | 50228-178-30 |
| ndc | 50228-178-01 |
| ndc | 50228-178-05 |
| code_info | Lot # G177092, Exp. 11/24 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0354-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.